References
Bushman W, Steers WD, Meythaler JM (1993) Voiding dysfunction in patients with spastic paraplegia: urodynamic evaluation and response to continuous intrathecal baclofen. Neurourol Urodyn 12:163–170. https://doi.org/10.1002/nau.1930120210
Dan B, Bouillot E, Bengoetxea A, Cheron G (2000) Effect of intrathecal baclofen on gait control in human hereditary spastic paraparesis. Neurosci Lett 280:175–178. https://doi.org/10.1016/S0304-3940(00)00778-3
Klebe S, Stolze H, Kopper F, Lorenz D, Wenzelburger R, Deuschl G, Volkmann J (2005) Objective assessment of gait after intrathecal baclofen in hereditary spastic paraplegia [6]. J Neurol 252:991–993
Margetis K, Korfias S, Boutos N, Gatzonis S, Themistocleous M, Siatouni A, Dalivigka Z, Flaskas T, Stranjalis G, Boviatsis E, Sakas D (2014) Intrathecal baclofen therapy for the symptomatic treatment of hereditary spastic paraplegia. Clin Neurol Neurosurg 123:142–145. https://doi.org/10.1016/j.clineuro.2014.05.024
Pucks-Faes E, Dobesberger J, Hitzenberger G, Matzak H, Mayr A, Fava E, Genelin E, Saltuari L (2019) Intrathecal baclofen in hereditary spastic paraparesis. Front Neurol 10. https://doi.org/10.3389/fneur.2019.00901
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Coulter, I.C., Lohkamp, L.N. & Ibrahim, G.M. Intrathecal baclofen for hereditary spastic paraplegia (HSP). Childs Nerv Syst 36, 1585–1587 (2020). https://doi.org/10.1007/s00381-020-04736-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-020-04736-x